New Key Statistics Module, Z-Score and F-Score
SHSE:603367 Key Ratios
Market Cap ¥ M | 6,338.56 |
Enterprise Value ¥ M | 4,032.64 |
P/E(ttm) | 11.97 |
PE Ratio without NRI | 10.79 |
Forward PE Ratio | 9.79 |
Price/Book | 1.09 |
Price/Sales | 1.44 |
Price/Free Cash Flow | 17.35 |
Price/Owner Earnings | 14.09 |
Payout Ratio % | 0.34 |
Revenue (TTM) ¥ M | 4,254.00 |
EPS (TTM) ¥ | 1.17 |
Beneish M-Score | -2.39 |
10-y EBITDA Growth Rate % | 4.30 |
5-y EBITDA Growth Rate % | -0.70 |
y-y EBITDA Growth Rate % | 26.30 |
EV-to-EBIT | 6.33 |
EV-to-EBITDA | 6.33 |
PEG | -- |
Shares Outstanding M | 452.75 |
Net Margin (%) | 12.43 |
Operating Margin % | 14.30 |
Pre-tax Margin (%) | 14.40 |
Quick Ratio | 2.63 |
Current Ratio | 3.19 |
ROA % (ttm) | 7.20 |
ROE % (ttm) | 9.17 |
ROIC % (ttm) | 13.89 |
Dividend Yield % | 4.69 |
Altman Z-Score | 4.33 |
SHSE:603367 Number of Guru Trades
SHSE:603367 Volume of Guru Trades
Gurus Latest Trades with SHSE:603367
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603367 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cisen Pharmaceutical Co Ltd Insider Transactions
No Available Data